by Fertility testing enables consumers to estimate days of ovulation and monitor fertility levels. Fertility tests are available in the form of urine and blood tests, saliva-based ovulation predictor kits, fertility monitors, and home-based ovulation microscopes. Home-based fertility testing kits provide convenience of self-testing without visiting a physician.
The global fertility test market is estimated to be valued at US$ 579.1 Mn in 2023 and is expected to exhibit a CAGR of 4.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics:
The fertility test market is witnessing robust growth owing to rising demand for advanced home-based fertility testing kits and devices. Home-based testing provides convenience and allows individuals to optimize their fertility without medical consultation. The covert nature of home kits also increases adoption as many wish to check fertility levels discreetly.
Another key factor augmenting market potential is growing awareness about ovulation cycles and importance of optimizing fertility levels. Social media influence and information-sharing has boosted understanding about fertility window periods and available testing options. Rising infertility rates globally are further prompting more individuals to closely monitor fertility levels and optimize conception chances using self-testing methods.
Segment Analysis
The global fertility test market is dominated by the over-the-counter sub-segment. This sub-segment held around 63% share of the total fertility test market in 2023 owing to the rising preference for self-monitoring fertility at home. The accessibility and ease of use are some key factors supporting the adoption of over-the-counter fertility tests.
PEST Analysis
Political: Various government initiatives to spread awareness about reproductive health and family planning are positively impacting the market growth. However, stringent regulations associated fertility testing products may hamper the revenues.
Economic: Rising per capita healthcare expenditure and growing focus on prevention and early detection of infertility issues are fueling the demand for fertility test kits. Additionally, working women delaying pregnancy decisions due to career aspirations has boosted market opportunities.
Social: Changing social perceptions regarding family planning and reproductive health management are encouraging more individuals to proactively plan their pregnancies. Growing acceptance of fertility tracking as a lifestyle change will additionally support the uptake of home-use test kits.
Technological: Introduction of digital fertility monitors, mobile applications, and advanced predictive algorithm are augmenting the user experience of fertility testing devices. Moreover, integration of AI and IoT further improves accuracy and convenience.
Key Takeaways
The Global Fertility Test Market Growth is estimated to be valued at US$ 579.1 Mn in 2023 and is expected to exhibit a CAGR of 4.9% over the forecast period 2023 to 2030.
North America is currently the largest as well as the fastest growing regional market for fertility tests. The rising prevalence of PCOS and increasing obesity rates which impair fertility are driving the demand in the region. North America is projected to account for around 35% share of the global fertility test market by 2024. Growing awareness about fertility issues and rising focus on early detection and management of female infertility disorders are some factors supporting early adoption of home-use tests. The strong presence of leading manufacturers is another key factor for the large share of the North American market.
Key players
Key players operating in the fertility test market are AstraZeneca, Novartis AG, GSP plc, Merck & Co., Inc., Verona Pharma plc, Regeneron Pharmaceuticals Inc., and Boehringer Ingelheim International GmbH.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
